Trials / Completed
CompletedNCT04766463
A Clinical Study of SHR8554 Injection for the Treatment of Pain After Abdominal Surgery.
A Phase III, Randomized, Double-Blind, Placebo- and Active-controlled Study of SHR8554 Injection for the Treatment of Pain After Abdominal Surgery.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 528 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to evaluate the analgesic efficacy of IV SHR8554 compared with placebo and morphine in patients with acute postoperative pain following abdominal surgery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR8554 Injection | SHR8554 Injection; high dose |
| DRUG | SHR8554 Injection | SHR8554 Injection; low dose |
| DRUG | Placebo | Saline Solution |
| DRUG | Morphine | Morphine |
Timeline
- Start date
- 2021-03-03
- Primary completion
- 2021-10-19
- Completion
- 2021-11-01
- First posted
- 2021-02-23
- Last updated
- 2022-07-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04766463. Inclusion in this directory is not an endorsement.